Abstract:Objective To observe the bone change before and after infliximab treatment in patients with ankylosing spondylitis ( AS) using ultrasonography, and to explore its clinical significance.Methods All the 48 cases of active AS patients met the modified New York criteria (1984), signed informed consent forms, and received 6 times of intravenous infusion of infliximab 5 mg/kg.Bone change on lower limb joints and tendon insertion sites in terms of morphology and blood flow after infliximab treatment was observed using high-resolution B ultrasonography and energy Doppler ultrasonography.Back pain VAS scores, joint swelling and pain, CRP, ESR, BASDAI, DASFI, and BASMI were recorded on week 0 and week 30, respectively.Results Forty-eight cases of AS patients completed the trial, and 31 of them had recheck using ultrasonography.Before the treatment, 37 sites of bone erosion, 2 sites of osteophyte, 17 sites of tendon thickening, 15 sites of bursitis, 1 site of tendon calcification, 22 sites of abnormal blood flow, 11 sites of joint effusion, and 1 site of synovial proliferation were found among the 48 cases using ultrasonography.Thirty weeks after infliximab treatment, 8 sites of bone erosion and 1 site of abnormal blood flow were found among the 31 patients who underwent recheck using ultrasonography.The difference was statistically significant ( P <0.01 ) compared to the amount before the treatment.Three sites of bursitis were found after the treatment, which was statistically different (P<0.05) compared to the amount before the treatment.There were 13 sites of bone erosion found in the tendons of greater trochanter of the femur and 7 sites in the medial collateral ligaments of knee joints before the treatment.However, only 2 sites in the tendons of greater trochanter of the femur and 2 sites in the medial collateral ligaments of knee joints remained after the treatment, and the difference was significant ( P<0.05 ) .Two sites of osteophyte remained after the treatment ( P>0.05 ) .All the clinical indicators improved after the treatment, and the difference was statistically significant ( P<0.01 ) compared to those before the treatment.Conclusion Ultrasonography can clearly show the formation of bone erosion and osteophyte on tendon insertion sites and joints, and indentify abnormities such as tendon thickening, bursitis, synovial proliferation, and abnormal blood flow. Particularly, it can reflect bone change in AS patients in a real-time manner and monitor the treatment efficacy.

Assessment of blood perfusion and image characteristics in patients with ankylosing spondylitis by color Doppler ultrasound: A case-control study

[Evaluation of Therapeutic Effects on Sacroiliitis and Enthesopathy in Ankylosing Spondylitis Patients by Color Ultrasound].

The evaluating value of color ultrasound for sacroiliitis and enthesopathy in ankylosing spondylitis

Evaluation of therapeutic effects on sacroiliitis in ankylosing spondylitis patients by color ultrasound

Preliminary evaluation of color power doppler ultrasonography in diagnosis of sacroiliitis in patients with ankylosing spondylitis

Evaluation of Complex Appearance in Vascularity of Sacroiliac Joint in Ankylosing Spondylitis by Color Doppler Ultrasonography

Scanning of the Sacroiliac Joint and Entheses by Color Doppler Ultrasonography in Patients with Ankylosing Spondylitis.

Value of T2mapping Sequence in the Evaluation on the Efficacy of Etanercept on Ankylosing Spondylitis

Feasibility of US-CT Image Fusion to Identify the Sources of Abnormal Vascularization in Posterior Sacroiliac Joints of Ankylosing Spondylitis Patients

Power Doppler Ultrasonography in the Evaluation of Infliximab Treatment for Sacroiliitis in Patients with Ankylosing Spondylitis.

Ultrasound Assessment of Entheses and Correlations Between Disease Activity and Ultrasound Scores in Ankylosing Spondylitis: A Cross Sectional Study

Ultrasonographic Evaluation of Sternoclavicular Joints in Ankylosing Spondylitis

Performance of ultrasound to monitor Achilles enthesitis in patients with ankylosing spondylitis during TNF-a antagonist therapy

Study of therapeutic effects of infliximab on bone in patients with ankylosing spondylitis using ultrasonography

Ultrasonographic Evaluation Of Enthesitis In Patients With Ankylosing Spondylitis

Ultrasound Assessment of Entheseal Sites and Anterior Chest Wall in Ankylosing Spondylitis: A Cross-Sectional Study.

Comparison of Angio PLanewave UltraSensitive and Power Doppler Ultrasound in Detecting Synovial Blood Flow in Wrist and Finger Joints of Rheumatoid Arthritis Patients

The Value of Contrast-Enhanced Ultrasonography to Detect the Sacroiliac Joint for Predicting Relapse after Discontinuation of Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis

The analysis of clinical characteristics and disease activity in ankylosing spondylitis patients with hyperuircemia

Ultrasound colour Doppler is associated with synovial pathology in biopsies from hand joints in rheumatoid arthritis patients: a cross-sectional study

The evaluation of bone marrow edema in sacroiliac joint in patients with ankylosing spondylitis using magnetic resonance imaging Dixon sequence